Cargando…
Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results
SIMPLE SUMMARY: Therapeutic guidance in non-small cell lung cancer (NSCLC) patients with discordant anaplastic lymphoma kinase (ALK) fluorescent in situ hybridization (+) where immunohistochemistry (IHC) (−) results are challenging. Selected reaction monitoring (SRM) quantitative multiplexed proteom...
Autores principales: | An, Ho Jung, An, Eunkyung, Rabizadeh, Shahrooz, Liao, Wei-Li, Burrows, Jon, Hembrough, Todd, Kang, Jin Hyung, Park, Chan Kwon, Kim, Tae-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150487/ https://www.ncbi.nlm.nih.gov/pubmed/34066104 http://dx.doi.org/10.3390/cancers13102337 |
Ejemplares similares
-
Decision making and ambiguity in auditory stream segregation
por: Deike, Susann, et al.
Publicado: (2015) -
Neural Correlates of Decision-Making Under Ambiguity and Conflict
por: Pushkarskaya, Helen, et al.
Publicado: (2015) -
P300 and Decision Making under Risk and Ambiguity
por: Wang, Lei, et al.
Publicado: (2015) -
Selective impairment of decision making under ambiguity in alexithymia
por: Zhang, Lei, et al.
Publicado: (2017) -
The Neurobase of ambiguity loss aversion about decision making
por: Hu, Yiqin, et al.
Publicado: (2023)